Business · 03/10/2017Updated: 10/17/2026 · 1 min read
Johnson & Johnson Consumer Inc. et al. Withdraws FDA-Approved Drugs
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 7 new drug applications and 71 abbreviated new drug applications from Johnson & Johnson Consumer Inc. and other applicants, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →